Coherus Oncology CHRS Cash Flow Statement (2013-2026)

NASDAQ CHRS
$0.99 -0.08 (-7.48%)
At close: Oct 16, 2026 · 4:00 PM EDT
Reported Financials

Coherus Oncology Quarterly Cash Flow Statement

Periods 52 quarters
Latest Jun 2026

Coherus Oncology reported cash from operations of -$62.09M and free cash flow of -$62.09M for the quarter ended Jun 2026, down 33.1% year over year. This cash flow statement covers 52 quarters of results from Sep 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-38.53M-45.73M-96.08M-50.15M-86.65M-58.87M-75.73M-42.87M-39.64M-79.65M102.88M-12.92M-10.75M-50.70M-56.57M297.77M-35.53M-37.64M-38.33M-20.63M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
1.09M1.11M3.70M0.98M0.95M0.80M0.66M0.57M0.58M0.60M
Depreciation & Amortization (CF)Dep. & Amort.
0.90M0.84M0.77M0.90M0.90M1.05M0.95M0.88M0.90M1.06M1.51M1.19M1.55M1.03M1.05M1.02M0.97M0.90M0.88M0.86M
Share-based CompensationStock Comp.
11.94M10.95M12.88M13.85M12.28M11.73M12.28M10.08M9.95M10.80M7.32M7.23M6.87M6.38M5.37M5.42M3.39M2.78M2.39M2.58M
Gains from Sales and DivestituresGains Divest
153.65M24.09M-1.09M-0.06M-0.42M-0.37M-0.39M-0.31M
Gains from Investment SecuritiesGains Investment
0.19M0.38M0.05M4.42M12.61M
Asset Writedowns and ImpairmentWritedown
-0.06M26.00M3.24M-0.35M1.48M48.23M6.77M7.37M12.45M
Other non-cash itemsOther Non-Cash
0.81M-0.50M6.81M0.62M0.64M0.66M0.55M-0.11M0.65M1.38M12.63M1.39M
Change in Working Capital
Change in ReceivablesChange Receivables
-5.48M-13.34M-5.99M-1.34M-24.52M18.80M-8.53M39.88M75.28M44.06M-8.58M-76.64M-7.81M-56.33M-50.89M-55.27M4.27M8.34M4.28M-8.22M
Change in InventoryChange Inventory
-6.80M9.19M2.96M11.24M23.35M9.79M2.67M13.04M19.23M11.79M11.46M7.10M6.94M6.45M22.24M-3.77M-2.48M1.11M11.31M-0.44M
Change in Account PayablesChange Payables
31.27M-29.62M4.76M-3.33M-7.57M1.60M11.74M6.05M6.76M-0.79M0.62M39.46M-50.36M6.34M13.04M-12.21M-15.30M-5.09M2.56M1.69M
Change in Accured ExpensesChange Accured Exp.
-9.94M1.41M-7.14M-1.44M40.90M-31.12M-21.91M12.62M0.48M19.73M1.56M-47.43M-5.03M-5.97M-8.33M-6.59M1.28M4.44M-7.16M-1.28M
Change in Other Operating AssetsOther Assets Change
6.25M-5.95M7.38M-7.65M19.74M-1.84M-3.92M-1.17M-9.72M-3.37M-5.16M2.24M1.65M-2.55M5.15M-4.67M-1.93M-3.66M-1.41M-3.15M
Change in Other Operating LiabilitiesOther Liabilities Change
0.99M-5.72M-7.13M-7.35M-10.53M0.44M1.24M25.15M34.22M52.50M-15.16M21.68M-14.14M1.55M-17.13M-50.92M-21.06M-30.21M-1.63M-0.73M
Other Working Capital ChangesOther WC Changes
-5.27M0.23M-14.52M0.30M-30.27M2.28M5.15M26.32M43.94M55.88M-1.42M-3.36M7.18M4.10M-1.84M-8.71M23.19M51.81M-3.30M-38.87M
Other Operating ActivitiesOther Ops.
-0.13M-0.43M0.63M-5.00M-2.89M1.05M0.71M1.21M0.86M1.63M-7.84M-4.98M0.47M-12.50M
Cash from OperationsCash from Ops.
13.71M-52.32M-54.05M-50.04M-37.09M-99.95M-68.73M-38.92M-54.30M-12.94M-46.77M59.73M-62.02M28.61M-25.83M-46.63M-46.34M-19.72M-57.89M-62.09M
Investing Activities
Capital ExpendituresCapex
0.26M0.47M0.62M0.88M0.46M0.09M0.15M0.10M0.03M-187.82M-40.00M4.72M-483.40M8.38M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.18M0.44M0.15M0.08M
Change in Property, Plant and EquipmentChange in PP&E
-0.26M-0.47M-0.62M-0.88M-0.46M-0.09M0.03M0.34M0.15M0.04M187.82M40.00M-4.72M483.40M-8.38M
Change in IntangiblesChange Intangibless
-187.82M
Acquisitions
Net of Acquisitions & DivestmentsNet Acquisitions
Purchase of InvestmentsInvestments Purchased
31.45M10.71M68.85M14.26M6.39M13.90M
Sale and Maturity of InvestmentsInvestments Sold
47.70M36.99M17.50M47.25M43.40M36.21M14.89M19.81M38.14M43.54M
Other Investing ActivitiesOther investing
0.03M0.34M0.15M-1.01M0.05M0.16M0.44M-0.54M-0.27M-0.04M-0.03M-0.01M-1.09M-0.01M
Cash from Investing ActivitiesCash from Investing
15.99M107.49M-35.62M-0.88M-0.46M-129.90M17.53M41.37M50.55M35.20M202.76M27.66M0.44M-0.54M-17.49M462.64M-67.23M-2.84M30.66M29.63M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
191.19M49.49M-0.14M
Long-Term Debt RepaymentsLT Debt Repayment
190.75M-81.75M
Non-Current Debt
0.44M49.49M81.75M-0.14M
Net Debt Issuances and RepaymentsNet Debt Issuance
0.44M49.49M81.75M-0.14M
Change in Capital Stock
Common Stock IssuedStock Issued
1.28M-39.21M0.54M1.66M0.08M0.73M0.10M1.35M0.05M1.00M0.29M0.39M1.70M8.06M53.65M0.20M
Shares Repurchased
Net Shares Issued and RepurchasedNet Shares Issued
1.28M-39.21M0.54M1.66M0.08M0.73M0.10M1.35M0.05M1.00M0.29M0.39M1.70M8.06M53.65M0.20M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
1.28M-39.21M0.54M1.66M0.08M0.73M0.10M1.35M0.05M1.00M0.29M0.39M1.70M8.06M53.65M0.20M
Other financing activitiesOther financing
-0.18M-1.96M-2.66M-0.64M-0.32M-4.23M-2.78M-0.31M-0.12M-4.05M-0.75M-1.71M-0.01M-2.49M-0.26M-0.02M0.00M-0.26M-0.11M0.12M
Cash from Financing ActivitiesCash from Financing
1.10M1.49M-1.86M0.72M48.87M6.59M3.80M54.33M11.11M0.37M0.89M-187.93M-0.17M0.23M-0.26M-281.52M0.00M8.08M53.59M0.14M
Additional items
Exchange Rate EffectFX Effect
Change in Cash
30.80M56.66M-91.52M-50.20M11.32M-223.26M-47.40M56.78M7.35M22.63M156.88M-100.54M-61.74M28.30M-43.58M134.48M-113.56M-14.47M26.36M-32.32M
Ending Cash Balance
103.34M260.23M159.69M97.95M126.25M82.67M217.16M103.59M89.12M115.48M83.16M
Free Cash FlowFCF
13.45M-52.79M-54.66M-50.92M-37.55M-100.04M-68.88M-39.02M-54.30M-12.97M141.06M99.73M-62.02M28.61M-30.55M436.77M-46.34M-28.09M-57.89M-62.09M
Net Cash FlowNCF
30.80M56.66M-91.52M-50.20M11.32M-223.26M-47.40M56.78M7.35M22.63M156.88M-100.54M-61.74M28.30M-43.58M134.48M-113.56M-14.47M26.36M-32.32M

Coherus Oncology Cash Flow Statement API

Pull Coherus Oncology's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CHRS&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY